GeneDx Holdings Corp. WGS
Super Investor & Insider
1
Fondi che lo detengono
#1163
Rank consenso
1.4%
% dei portafogli
$5.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.03% | Add 29.33% | 77,419 | $5.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
GeneDx Holdings Corp. is a leading genomics company specializing in genetic testing services for the diagnosis of rare and complex genetic disorders. It provides advanced whole exome and genome sequencing, along with targeted gene panels and microarray testing, to deliver rapid, precise, and actionable clinical insight…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees1,300
TickerWGS
Statistics
Market Cap$1.68B
Revenue (TTM)$427.5M
Net Income-$21.0M
Net Margin-4.9%
EPS$-0.73
P/E724.64
P/S4.02
P/B5.69
EV/EBITDA-226.29
ROE-30.4%
Dividend Yield—
Price$56.51
Data: Twelve Data · Revenue = mcap / P/S